Evidence-based treatment for opiate-dependent clients: Availability, variation, and organizational correlates

American Journal of Drug and Alcohol Abuse

Volumn 32, Issue 4, 2006, Pages 569-576

  Ducharme, Lori J ^a   Knudsen, Hannah K ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

Evidence based practice; Innovation; Opiate addiction; Treatment

Indexed keywords

BUPRENORPHINE; METHADONE; NALTREXONE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EVIDENCE BASED PRACTICE; HEALTH CARE FACILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JOB FINDING; MAJOR CLINICAL STUDY; OPIATE ADDICTION; PATIENT CARE; PATIENT COUNSELING; PSYCHOPHARMACOTHERAPY;

COUNSELING; EVIDENCE-BASED MEDICINE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERVIEWS; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE TREATMENT CENTERS;

EID: 33845331677     PISSN: 00952990     EISSN: 10979891     Source Type: Journal    
DOI: 10.1080/00952990600920417     Document Type: Article

References (12)

1. SAMHSA. The DASIS Report: Facilities Providing Methadone/LAAM Treatment to Clients with Opiate Addiction. Rockville, MD: SAMHSA/OAS, 2002b.
2. Downey L, Rosengren DB, Jackson TR, Donovan DM. Primary heroin use+drug-free treatment: An equation for success? Addict Behav 2003; 28:339-346.
3. Hser YI, Anglin MD, Fletcher B. Comparative treatment effectiveness: Effects of program modality and client drug dependence history on drug use reduction. J Subst Abuse Treat 1998; 15:513-523.
4. Substance Abuse and Mental Health Data Archive. Online analysis for the Treatment Episode Data Set (TEDS), 2000. www.icpsr.umich.edu/samhda (Accessed December 11, 2003).
5. Rhodes GL, Saules KK, Helmus TC, Roll J, BeShears RB, Ledgerwood DM, Schuster CR. Improving on-time counseling attendance in a methadone treatment program: A contingency management approach. Am J Drug Alcohol Abuse 2003; 29(4):759-773.
6. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL. Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend 1996; 41:157-165.
7. Broome KM, Joe GW, Simpson DD. HIV risk reduction in outpatient drug abuse treatment: Individual and geographic differences. AIDS Education and Prevention 1999; 11:293-306.
8. Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, DePhillippis D, Stolley P, Abrutyn E. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: An eighteen-month prospective follow-up. Journal of Acquired Immune Deficiency Syndrome 1993; 6:1049-1056.
9. Kidorf M, Neufeld K, Brooner RK. Combining stepped-care approaches with behavioral reinforcement to motivate employment in opioid-dependent outpatients. Substance Use & Misuse 2004; 39:2215-2238.
10. Condelli WS, Dunteman GH. Exposure to methadone programs and heroin use. American Journal on Drug and Alcohol Abuse 1993; 19:65-78.
11. Knudsen HK, Ducharme LJ, Roman PM. Early buprenorphine adoption in substance abuse treatment centers: Data from the public and private sectors. Journal of Substance Abuse Treatment 2006; 30:363-373.
12. Ducharme LJ, Knudsen HK, Roman PM. Computer systems in addiction treatment programs: Availability and implications for program evaluation. Evaluation and Program Planning 2005; 28:368-378.